Zogenix (ZGNX) Stock: Tumbling On FDA Rejection
Zogenix, Inc. (NASDAQ: ZGNX) is having an incredibly rough start to the trading session in the pre-market hours this morning, and for good reason. The comapny announced a rejection from the FDA, upsetting investors and sending the stock tumbling. Today, we’ll talk about: The rejection; what we’re seeing from ZGNX stock as a result; and … Read more